 Connection
Cathy Bradley to Antineoplastic Agents
This is a "connection" page, showing publications Cathy Bradley has written about Antineoplastic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.606 |
|
|
|
-
Bradley CJ, Eguchi M, Perraillon MC. Factors Associated With Use of High-Cost Agents for the Treatment of Metastatic Non-Small Cell Lung Cancer. J Natl Cancer Inst. 2020 08 01; 112(8):802-809.
Score: 0.339
-
Bradley CJ. Cancer, Financial Burden, and Medicare Beneficiaries. J Clin Oncol. 2017 08 01; 35(22):2461-2462.
Score: 0.272
-
Bradley CJ, Yabroff KR, Mariotto AB, Zeruto C, Tran Q, Warren JL. Antineoplastic Treatment of Advanced-Stage Non-Small-Cell Lung Cancer: Treatment, Survival, and Spending (2000 to 2011). J Clin Oncol. 2017 Feb 10; 35(5):529-535.
Score: 0.264
-
Bradley CJ, Yabroff KR, Warren JL, Zeruto C, Chawla N, Lamont EB. Trends in the Treatment of Metastatic Colon and Rectal Cancer in Elderly Patients. Med Care. 2016 May; 54(5):490-7.
Score: 0.252
-
Bradley CJ. Financial hardship: a consequence of survivorship? J Clin Oncol. 2012 May 10; 30(14):1579-80.
Score: 0.189
-
Bradley CJ, Dahman B, Jin Y, Shickle LM, Ginder GD. Acute myeloid leukemia: how the uninsured fare. Cancer. 2011 Oct 15; 117(20):4772-8.
Score: 0.177
-
Bradley CJ, Brown KL, Haan M, Glasgow RE, Newman LS, Rabin B, Ritzwoller DP, Tenney L. Cancer Survivorship and Employment: Intersection of Oral Agents, Changing Workforce Dynamics, and Employers' Perspectives. J Natl Cancer Inst. 2018 12 01; 110(12):1292-1299.
Score: 0.075
-
Bradley CJ, Dahman B, Given CW. Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. J Clin Oncol. 2008 Nov 01; 26(31):5067-73.
Score: 0.037
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|